Filing Details

Accession Number:
0001494650-20-000159
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2020-12-08 16:35:41
Reporting Period:
2020-11-23
Accepted Time:
2020-12-08 16:35:41
Original Submission Date:
2020-11-26
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1494650 Optinose Inc. OPTN Pharmaceutical Preparations (2834) 421771610
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1718725 A Ramy Mahmoud C/O Optinose, Inc.
1020 Stony Hill Road, Suite 300
Yardley PA 19067
President And Coo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-11-23 130,995 $1.63 199,977 No 4 M Direct
Common Stock Disposition 2020-11-23 41,214 $4.50 158,763 No 4 S Direct
Common Stock Disposition 2020-11-23 43,651 $4.50 115,112 No 4 F Direct
Common Stock Acquisiton 2020-11-23 43,629 $1.63 48,112 No 4 M Indirect By: The Ramy Mahmoud 2014 Trust for Cynthia Mahmoud
Common Stock Disposition 2020-11-23 13,746 $4.50 34,366 No 4 S Indirect By: The Ramy Mahmoud 2014 Trust for Cynthia Mahmoud
Common Stock Disposition 2020-11-23 13,598 $4.50 20,768 No 4 F Indirect By: The Ramy Mahmoud 2014 Trust for Cynthia Mahmoud
Common Stock Acquisiton 2020-11-24 37,466 $1.63 152,578 No 4 M Direct
Common Stock Disposition 2020-11-24 10,593 $4.39 141,985 No 4 S Direct
Common Stock Disposition 2020-11-24 14,046 $4.39 127,939 No 4 F Direct
Common Stock Acquisiton 2020-11-24 12,496 $1.63 33,264 No 4 M Indirect By: The Ramy Mahmoud 2014 Trust for Cynthia Mahmoud
Common Stock Disposition 2020-11-24 3,533 $4.39 29,731 No 4 S Indirect By: The Ramy Mahmoud 2014 Trust for Cynthia Mahmoud
Common Stock Disposition 2020-11-24 4,684 $4.39 25,047 No 4 F Indirect By: The Ramy Mahmoud 2014 Trust for Cynthia Mahmoud
Common Stock Acquisiton 2020-11-25 10,467 $1.63 138,406 No 4 M Direct
Common Stock Disposition 2020-11-25 2,931 $4.32 135,475 No 4 S Direct
Common Stock Disposition 2020-11-25 3,987 $4.32 131,488 No 4 F Direct
Common Stock Acquisiton 2020-11-25 3,489 $1.63 28,536 No 4 M Indirect By: The Ramy Mahmoud 2014 Trust for Cynthia Mahmoud
Common Stock Disposition 2020-11-25 977 $4.32 27,559 No 4 S Indirect By: The Ramy Mahmoud 2014 Trust for Cynthia Mahmoud
Common Stock Disposition 2020-11-25 1,328 $4.32 26,231 No 4 F Indirect By: The Ramy Mahmoud 2014 Trust for Cynthia Mahmoud
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 F Direct
No 4 M Indirect By: The Ramy Mahmoud 2014 Trust for Cynthia Mahmoud
No 4 S Indirect By: The Ramy Mahmoud 2014 Trust for Cynthia Mahmoud
No 4 F Indirect By: The Ramy Mahmoud 2014 Trust for Cynthia Mahmoud
No 4 M Direct
No 4 S Direct
No 4 F Direct
No 4 M Indirect By: The Ramy Mahmoud 2014 Trust for Cynthia Mahmoud
No 4 S Indirect By: The Ramy Mahmoud 2014 Trust for Cynthia Mahmoud
No 4 F Indirect By: The Ramy Mahmoud 2014 Trust for Cynthia Mahmoud
No 4 M Direct
No 4 S Direct
No 4 F Direct
No 4 M Indirect By: The Ramy Mahmoud 2014 Trust for Cynthia Mahmoud
No 4 S Indirect By: The Ramy Mahmoud 2014 Trust for Cynthia Mahmoud
No 4 F Indirect By: The Ramy Mahmoud 2014 Trust for Cynthia Mahmoud
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2020-11-23 130,995 $0.00 130,995 $1.63
Common Stock Stock Option (Right to Buy) Disposition 2020-11-23 43,629 $0.00 43,629 $1.63
Common Stock Stock Option (Right to Buy) Disposition 2020-11-24 37,466 $0.00 37,466 $1.63
Common Stock Stock Option (Right to Buy) Disposition 2020-11-24 12,496 $0.00 12,496 $1.63
Common Stock Stock Option (Right to Buy) Disposition 2020-11-25 10,467 $0.00 10,467 $1.63
Common Stock Stock Option (Right to Buy) Disposition 2020-11-25 3,489 $0.00 3,489 $1.63
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
132,949 2021-02-11 No 4 M Direct
44,326 2021-02-11 No 4 M Indirect
95,483 2021-02-11 No 4 M Direct
31,830 2021-02-11 No 4 M Indirect
85,016 2021-02-11 No 4 M Direct
28,341 2021-02-11 No 4 M Indirect
Footnotes
  1. Footnote No. 1 in the Form 4 originally filed on November 26, 2020 contained a clerical error regarding the number of reported options exercised, held and canceled by the Reporting Person on November 23, 2020. Footnote No. 1 is hereby corrected as follows: The reporting person previously entered into a 10b5-1 trading plan ("10b5-1 Plan") with respect to stock options granted on 2/11/11 and set to expire on 2/11/21. On November 23, 2020, 130,995 options were exercised pursuant to the terms of the 10b5-1 Plan resulting in the reporting person's receipt of 46,130 shares of common stock, the cancellation of 43,651 option shares in satisfaction of the exercise price for certain of the options and the sale of 41,214 shares to cover the payment of the exercise price for certain of the options and to cover estimated withholding taxes in connection with such exercise.
  2. Footnote No. 1 in the Form 4 originally filed on November 26, 2020 contained a clerical error regarding the number of reported options exercised, held and canceled by the Reporting Person on November 23, 2020. Footnote No. 1 is hereby corrected as follows: The Ramy Mahmoud 2014 Trust for Cynthia Mahmoud (the "Trust") previously entered into a 10b5-1 trading plan ("10b5-1 Plan") with respect to stock options granted on 2/11/11 and set to expire on 2/11/21. On November 23, 2020, 43,629 options were exercised pursuant to the terms of the 10b5-1 Plan resulting in the reporting person's receipt of 16,285 shares of common stock, the cancellation of 13,598 option shares in satisfaction of the exercise price for certain of the options and the sale of 13,746 shares to cover the paymen tof the exercise price for certain of the options and to cover estimated withholding taxes in connection with such exercise.
  3. Shares held by The Ramy Mahmoud 2014 Trust for Cynthia Mahmoud, the beneficiary of which is Dr. Mahmoud's spouse.
  4. The reporting person previously entered into a 10b5-1 trading plan ("10b5-1 Plan") with respect to stock options granted on 2/11/11 and set to expire on 2/11/21. On November 24, 2020, 37,466 options were exercised pursuant to the terms of the 10b5-1 Plan resulting in the reporting person's receipt of 12,827 shares of common stock, the cancellation of 14,046 option shares in satisfaction of the exercise price for such options and the sale of 10,593 shares to cover estimated withholding taxes in connection with such exercise.
  5. The Ramy Mahmoud 2014 Trust for Cynthia Mahmoud (the "Trust") previously entered into a 10b5-1 trading plan ("10b5-1 Plan") with respect to stock options granted on 2/11/11 and set to expire on 2/11/21. On November 24, 2020, 12,496 options were exercised pursuant to the terms of the 10b5-1 Plan resulting in the reporting person's receipt of 4,279 shares of common stock, the cancellation of 4,684 option shares in satisfaction of the exercise price for such options and the sale of 3,533 shares to cover estimated withholding taxes in connection with such exercise.
  6. The reporting person previously entered into a 10b5-1 trading plan ("10b5-1 Plan") with respect to stock options granted on 2/11/11 and set to expire on 2/11/21. On November 25, 2020, 10,467 options were exercised pursuant to the terms of the 10b5-1 Plan resulting in the reporting person's receipt of 3,549 shares of common stock, the cancellation of 3,987 option shares in satisfaction of the exercise price for such options and the sale of 2,931 shares to cover estimated withholding taxes in connection with such exercise.
  7. The Ramy Mahmoud 2014 Trust for Cynthia Mahmoud (the "Trust") previously entered into a 10b5-1 trading plan ("10b5-1 Plan") with respect to stock options granted on 2/11/11 and set to expire on 2/11/21. On November 25, 2020, 3,489 options were exercised pursuant to the terms of the 10b5-1 Plan resulting in the reporting person's receipt of 1,184 shares of common stock, the cancellation of 1,328 option shares in satisfaction of the exercise price for such options and the sale of 977 shares to cover estimated withholding taxes in connection with such exercise.
  8. All option shares are exercisable.